Does vitamin A status affect thyroid hormone signaling?

Vitamin A and thyroid hormones share an intimate biochemical relationship that is critical for systemic metabolism, gene expression, and endocrine feedback loops.

Molecular and mechanistic interactions

• Receptor Heterodimerization: Thyroid hormone receptors (TRs) preferentially bind to thyroid hormone response elements (TREs) on DNA as heterodimers with the Retinoid X Receptor (RXR).
• Allosteric Cooperativity: The binding of thyroid hormone (T3) and the RXR ligand (9-cis-retinoic acid) triggers cooperative conformational changes. Depending on the TRE structure, these ligands can act synergistically to enhance transcription or exhibit negative cooperativity to temper the T3-driven response.
• Isoform Regulation: Retinoid signaling also alters pathway sensitivity by regulating specific receptor isoforms, such as blunting the downregulation of TRβ2 mRNA.

Central and peripheral thyroid disruption

• Central HPT Axis Regulation: Retinoids act as direct negative regulators of thyroid-stimulating hormone (TSH) transcription. Vitamin A deficiency (VAD) relieves this physiological inhibition, resulting in increased pituitary TSH-beta mRNA and elevated circulating TSH levels.
• Peripheral Conversion and Uptake: Low vitamin A status reduces the hepatic conversion of thyroxine (T4) to the active triiodothyronine (T3) form, leading to a low-T3 biochemical state. Additionally, VAD impairs cellular T3 uptake and tissue-level binding.
• Transcriptional Dampening: Without sufficient vitamin A, shared RAR/RXR and TR complexes cannot be properly activated, reducing target gene transcription in peripheral tissues. Clinical replenishment of vitamin A has been shown to restore T4-to-T3 conversion and reduce elevated TSH.

Bottom line

• Vitamin A status is a key determinant of thyroid function; deficiency impairs central hypothalamic-pituitary-thyroid (HPT) feedback—disinhibiting TSH secretion—and blunts peripheral thyroid hormone signaling by reducing hepatic T4-to-T3 conversion and disrupting RXR-TR nuclear receptor transcription.